Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001174947-24-001081
Filing Date
2024-09-18
Accepted
2024-09-18 09:02:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-T/A sctot0924_asahikasei.htm SC TO-T/A 61253
2 ENGLISH VERSION OF SWEDISH PRESS RELEASE DATED SEPTEMBER 16, 2024.* sctot0924exa5t_asahika.htm EX-99.(A)(5)(T) 33596
  Complete submission text file 0001174947-24-001081.txt   96471
Mailing Address 1-105 KANDA JINBOCHO, CHIYODA-KU TOKYO M0 1018101
Business Address 1-105 KANDA JINBOCHO, CHIYODA-KU TOKYO M0 1018101 81 3 3296 3005
Asahi Kasei Corp (Filed by) CIK: 0001446531 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC TO-T/A
SIC: 8880 American Depositary Receipts
(CF Office: International Corp Fin)

Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

EIN.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91523 | Film No.: 241306277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)